
HLN Stock Analysis
Haleon plc
HEALTHCARE
DRUG MANUFACTURERS - SPECIALTY & GENERIC
Performance Overview
Trailing adjusted-close returns as of 2026-07-10. Benchmark is SPY.
YTD Return
1-Year Return
3-Year Return
5-Year Return
Returns are calculated from adjusted close prices and may differ from broker or research-site totals depending on data source, dividend handling, benchmark choice, and latest available trading date.
Legacy Screening Checks
This page uses cached SQL data from the latest StockValueFinder scan, so it loads fast without hitting Alpha Vantage on every page view.
Looks for positive and improving earnings per share.
Looks for strong return on invested capital.
Checks whether operating income comfortably covers interest expense.
Checks whether free cash flow could pay down long-term debt quickly.
Checks whether valuation is reasonable under the current rule set.
Uses 20-day, 50-day, and 200-day moving averages for entry timing context.
Cached Technical Data
Moving average values from the latest stored scan.
Latest Published Stock Research
Research generated: October 24, 2026
HLN Stock Analysis: Why Haleon plc Scored 43% in Stock Value Finder
Haleon plc (HLN): An Educational StockValueFinder Review
Haleon plc is a healthcare company specializing in drug manufacturing within the specialty and generic sector. This article serves as an educational review of Haleon's stock based on the metrics provided by StockValueFinder, a tool designed to evaluate stocks using specific financial criteria.
Why the StockValueFinder Score Matters StockValueFinder evaluates companies across various financial metrics to provide an overall score that reflects their investment quality. For Haleon plc (HLN), the current score is 43%, which results in a rating of "AVOID." This means that based on the provided data, Haleon does not meet the criteria for being considered a high-quality stock according to StockValueFinder's standards.
EPS Strength and Consistency Earnings Per Share (EPS) measures how much profit a company generates per share. A consistent EPS is crucial as it indicates financial stability and profitability over time. For Haleon, the EPS test was passed, meaning that the system has confirmed the company’s earnings consistency based on historical data. However, without specific EPS values, we cannot provide exact figures for comparison. Generally, investors look for companies with increasing or stable EPS over multiple reporting periods to gauge financial health.
**Example:** A company with an EPS of $2 per share this year and $1.80 last year shows improvement, whereas a decrease from $2 to $1.50 would be concerning.
ROIC and Capital Efficiency Return on Invested Capital (ROIC) measures how effectively a company uses its capital to generate profits. A higher ROIC indicates better use of resources. Haleon's ROIC is 6.52%, which falls below the preferred range of 10% or higher set by StockValueFinder. This suggests that Haleon may not be utilizing its capital as efficiently as more favorable companies.
**Example:** If Company A has an ROIC of 15% and Company B has an ROIC of 4%, Company A is likely using its capital better, indicating stronger financial performance.
Interest Coverage and Financial Safety Interest coverage measures a company's ability to pay interest on outstanding debt. StockValueFinder prefers companies with interest coverage ratios of at least 6 times earnings before interest, taxes, depreciation, and amortization (EBITDA). Haleon passed this test, meaning it has sufficient earnings to cover its interest expenses comfortably.
**Example:** A ratio of 8x is healthier than a ratio of 2x because the company with an 8x ratio can easily handle higher debt levels without financial strain.
Debt Payback and Balance Sheet Discipline Debt payback measures how long it would take for a company to repay all its outstanding debt using current earnings before interest and taxes (EBIT). StockValueFinder prefers companies that can repay their debt within three years or less. Haleon's debt payback period is 3.89 years, which does not meet the preferred criteria.
**Example:** A company with a debt payback of 1.5 years is in better financial shape than one with a payback period of 7 years because it can clear its debts faster and reduce risk exposure.
P/E Ratio and Valuation Discipline The Price-to-Earnings (P/E) ratio compares a stock's market value to its earnings per share, indicating the price investors are willing to pay for each dollar of earnings. StockValueFinder generally prefers companies with a P/E ratio of 15 or lower as it suggests better valuation discipline. Haleon’s current P/E ratio is 21.16, which does not align with the preferred range.
**Example:** A company trading at a P/E of 8 may be more value-oriented than one trading at 40, assuming both companies have similar business quality and growth prospects.
Moving Average Trend and Entry Timing The moving average signal for Haleon is "NEUTRAL / WATCH," indicating that the stock price has been fluctuating around its long-term trend without a clear upward or downward movement. The entry signal is "N/A," suggesting no specific buy point based on trend analysis alone.
**Example:** If a stock's 50-day moving average crosses above its 200-day moving average, it might indicate a potential buying opportunity due to positive momentum.
Overall Financial Strengths and Weaknesses Haleon’s financial strengths include passing the EPS test and interest coverage tests. However, weaknesses are evident in ROIC (6.52%), debt payback (3.89 years), and P/E ratio (21.16). These metrics suggest that while Haleon may have some stability in earnings and ability to cover interest expenses, it faces challenges in capital efficiency, debt repayment speed, and valuation.
Risks and Limitations The risks associated with investing in Haleon include potential difficulties in improving ROIC, extending time needed to repay debts, and overvaluation as indicated by the P/E ratio. Additionally, the lack of specific entry signals means that timing the purchase or sale based on trend analysis is not straightforward.
Educational Conclusion This review highlights how StockValueFinder evaluates companies across multiple financial metrics to provide a comprehensive score and rating. For Haleon plc (HLN), while there are some positive aspects like EPS consistency and interest coverage, the overall score of 43% with an "AVOID" recommendation indicates that it may not be a suitable investment based on current data.
Understanding these metrics and their implications is crucial for investors looking to make informed decisions. By analyzing EPS strength, ROIC, debt payback, P/E ratio, and other financial indicators, one can better assess the quality of stocks and align investments with personal risk tolerance and financial goals.
This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.
Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings
30-Day Trendline Analysis
Optional intraday chart with rising support, falling resistance, and multi-timeframe views.